These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24659331)

  • 1. Serum amyloid-A in Behçet's disease.
    Vitale A; Rigante D; Lopalco G; Brizi MG; Caso F; Franceschini R; Denaro R; Galeazzi M; Punzi L; Iannone F; Lapadula G; Simpatico A; Marrani E; Costa L; Cimaz R; Cantarini L
    Clin Rheumatol; 2014 Aug; 33(8):1165-7. PubMed ID: 24659331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease.
    Sota J; Vitale A; Rigante D; Orlando I; Lucherini OM; Simpatico A; Lopalco G; Franceschini R; Galeazzi M; Frediani B; Fabiani C; Tosi GM; Cantarini L
    Isr Med Assoc J; 2018 Aug; 20(8):517-521. PubMed ID: 30084580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.
    Lucherini OM; Vitale A; Orlando I; Sota J; Fabiani C; Franceschini R; Simpatico A; Frediani B; Galeazzi M; Tosi GM; Cantarini L
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):110-115. PubMed ID: 30582507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
    Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
    Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.
    Lopalco G; Lucherini OM; Vitale A; Talarico R; Lopalco A; Galeazzi M; Lapadula G; Cantarini L; Iannone F
    Medicine (Baltimore); 2015 Oct; 94(42):e1858. PubMed ID: 26496336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease.
    Lee HJ; Kim JH; Kim SW; Joo HA; Lee HW; Kim YS; Park SJ; Hong SP; Kim TI; Kim WH; Kim YH; Cheon JH
    Dig Dis Sci; 2017 Aug; 62(8):1953-1962. PubMed ID: 28523576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
    Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
    J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum beta 2-microglobulin reflects disease activity in Behçet's disease.
    Aygündüz M; Bavbek N; Oztürk M; Kaftan O; Koşar A; Kirazli S
    Rheumatol Int; 2002 May; 22(1):5-8. PubMed ID: 12120912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease.
    Er H; Evereklioglu C; Cumurcu T; Türköz Y; Ozerol E; Sahin K; Doganay S
    Br J Ophthalmol; 2002 Jun; 86(6):653-7. PubMed ID: 12034688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens.
    Cantarini L; Pucino V; Vitale A; Talarico R; Lucherini OM; Magnotti F; De Rosa V; Galgani M; Alviggi C; Marone G; Galeazzi M; Matarese G
    Clin Exp Immunol; 2016 May; 184(2):197-207. PubMed ID: 26756979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
    Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
    Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of serum amyloid-A in Behçet's disease.
    Agilli M; Aydin FN; Kurt YG; Cayci T
    Clin Rheumatol; 2016 Feb; 35(2):551-2. PubMed ID: 25586523
    [No Abstract]   [Full Text] [Related]  

  • 14. Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease.
    Icli A; Cure MC; Cure E; Arslan S; Unal M; Sakiz D; Ozucan M; Toker A; Turkmen K; Kucuk A
    Acta Medica (Hradec Kralove); 2018; 61(3):86-92. PubMed ID: 30543512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement.
    Yalçindağ FN; Batioğlu F; Ozdemir O; Cansizoğlu E; Eğin Y; Akar N
    Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
    Atıl A; Deniz A
    Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
    Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.
    Yuksel M; Yildiz A; Oylumlu M; Turkcu FM; Bilik MZ; Ekinci A; Elbey B; Tekbas E; Alan S
    Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker?
    Evereklioglu C; Turkoz Y; Er H; Inaloz HS; Ozbek E; Cekmen M
    J Am Acad Dermatol; 2002 Jan; 46(1):50-4. PubMed ID: 11756945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
    de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.